Mei-ling Smith is a Boston, Massachusetts based nurse practitioner. Her current practice location is 1153 Centre St, Dana-farber/brigham & Women's Cancer Center At Faulkner, Boston. Patients can reach her at 617-983-7160 or can fax her at 617-983-7860. Mei-ling Smith is NP and her NPI number (Unique professional ID assigned by NPPES) is 1104863174. Mei-ling Smith has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Mei-ling Smith speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Mei-ling Smith
Specialization:
Nurse Practitioner (NP)
Gender:
Female
Credentials:
NP
Practice Address:
1153 Centre St, Dana-farber/brigham & Women's Cancer Center At Faulkner, Boston, Massachusetts, 02130-3446
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1104863174
NPI Enumeration Date:
31 May, 2006
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Mei-ling Smith 27 Cotton St, #3 Roslindale, Massachusetts
Zip:
02131-1609
Phone Number:
617-983-7160
Fax Number:
617-983-7860
Patients can reach Mei-ling Smith at 1153 Centre St, Dana-farber/brigham & Women's Cancer Center At Faulkner, Boston, Massachusetts or can call to book an appointment on 617-983-7160.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.